Lone Pine Capital added $1.8 billion in consumer staples and healthcare names during Q4 2024, according to its latest 13F filing. The firm exited or trimmed 14 technology positions while building stakes in Procter & Gamble, Johnson & Johnson, and Constellation Brands — the largest single-quarter rotation into defensives since early 2022. Tiger Global moved the opposite direction, increasing software exposure by $2.1 billion and cutting consumer discretionary by 32%.
The divergence marks the widest positioning gap among mega-allocators in eighteen months. Lone Pine's portfolio beta dropped to 0.71 from 0.94 quarter-over-quarter. Tiger's rose to 1.18. Coatue and D1 Capital filed similar patterns to Tiger, concentrating in AI infrastructure and enterprise SaaS. Greenlight Capital disclosed new energy shorts and a $640 million increase in gold miners — the firm's first meaningful commodity exposure since 2020. The filings suggest institutional disagreement on whether the February selloff represents a durable regime shift or a technical correction within an intact bull market.
The staples rotation matters because Lone Pine historically leads allocator sentiment shifts by two quarters. The firm's 2022 move into energy preceded the sector's eighteen-month outperformance. Its 2023 tech re-entry came three months before the Magnificent Seven rally began. Current positioning implies the firm expects sustained volatility or policy uncertainty through mid-2025. Consumer staples typically underperform in growth regimes but provide ballast when correlations spike — exactly what Lone Pine appears to be hedging.
Tiger's counter-positioning creates the tactical opportunity. If the firm is wrong and rates stay elevated longer than software multiples can tolerate, the unwind will be abrupt. Tiger's Q4 additions included $890 million in Snowflake, Datadog, and ServiceNow — names trading at 9-12x forward revenue despite decelerating growth. The portfolio now carries 43% software exposure, the highest since Q1 2021. That concentration worked when the Fed pivoted dovish. It hasn't worked since November.
Allocators should track three events over the next sixty days. First, whether Lone Pine adds to its staples positions in the current quarter — the firm typically completes rotations over two filing periods. Second, how Tiger's longs perform if the 10-year yield breaks 4.8% again, which would pressure software multiples further. Third, whether other Tiger Cubs follow Coatue's move into AI infrastructure or Lone Pine's move into defensives. The next meaningful data point is March options expiry, when positioning often clarifies.
The 13F divergence is the fact. Lone Pine doesn't rotate into Procter & Gamble because it expects a soft landing.